Do you want to read an article? Please log in or register.
Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study
Migraine and Headache
Related content
Migraine and Headache
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study
Cephalalgia
Raffaelli B, Terhart M, Overeem LH, Mecklenburg J, Neeb L, Steinicke M, Reuter U
doi: 10.1177/03331024211046617
Migraine and Headache
Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study
Cephalalgia
Gantenbein AR, Agosti R, Gobbi C, Flügel D, Schankin CJ, Viceic D, Zecca C, Pohl H
doi: 10.1177/03331024211014616
Migraine and Headache
Onabotulinumtoxin-A in Chronic Migraine: Should Timing and Definition of Non-Responder Status Be Revised? Suggestions From a Real-Life Italian Multicenter Experience
Headache.
Vernieri F, Paolucci M, Altamura C, Pasqualetti P, Mastrangelo V, Pierangeli G, Cevoli S, D'Amico D, Grazzi L
doi: 10.1111/head.13617.
Migraine and Headache
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study
Headache
Kawata AK, Shah N, Poon JL, Shaffer S, Sapra S, Wilcox TK, Shah S, Tepper SJ, Dodick DW, Lipton RB
doi: 10.1111/head.14053
RECOMMENDED
Migraine and Headache
A Real-World Analysis of Patient Characteristics, Treatment Patterns, and Level of Impairment in Patients With Migraine Who are Insufficient Responders vs Responders to Acute Treatment
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Headache.
Lombard L, Ye W, Nichols R, Jackson J, Cotton S, Joshi S
doi: 10.1111/head.13835.
Migraine and Headache
My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed
J Headache Pain.
Martelletti P, Schwedt TJ, Lanteri-Minet M, Quintana R, Carboni V, Diener HC, Ruiz de la Torre E, Craven A, Rasmussen AV, Evans S, Laflamme AK, Fink R, Walsh D, Dumas P, Vo P
doi: 10.1186/s10194-018-0946-z.
RECOMMENDED
Migraine and Headache
Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study
Neurology.
Kuca B, Silberstein SD, Wietecha L, Berg PH, Dozier G, Lipton RB; COL MIG-301 Study Group
doi: 10.1212/WNL.
Migraine and Headache
Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class
Headache.
Hargreaves R, Olesen J
doi: 10.1111/head.13510.
RECOMMENDED
Psychosis and Schizophrenia
Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study
Lancet Psychiatry.
Jukic MM, Smith RL, Haslemo T, Molden E, Ingelman-Sundberg M
doi: 10.1016/S2215-0366(19)30088-4.